FibroGen, Inc.
FGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $114 | $156 | $171 |
| Short-Term Investments | $0 | $122 | $266 | $234 |
| Receivables | $0 | $41 | $16 | $25 |
| Inventory | $3 | $42 | $40 | $31 |
| Other Curr. Assets | $142 | $13 | $14 | $12 |
| Total Curr. Assets | $197 | $332 | $493 | $474 |
| Property Plant & Equip (Net) | $0 | $81 | $100 | $119 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $5 | $9 | $172 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $18 | $5 | $7 | $9 |
| Total NC Assets | $18 | $92 | $117 | $300 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $215 | $424 | $610 | $774 |
| Liabilities | – | – | – | – |
| Payables | $5 | $18 | $31 | $26 |
| Short-Term Debt | $0 | $14 | $10 | $11 |
| Tax Payable | $0 | $7 | $8 | $13 |
| Deferred Revenue | $0 | $13 | $13 | $19 |
| Other Curr. Liab. | $128 | $166 | $212 | $157 |
| Total Curr. Liab. | $133 | $218 | $274 | $225 |
| LT Debt | $90 | $156 | $80 | $89 |
| Deferred Rev, NC | $0 | $158 | $186 | $187 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $175 | $54 | $73 | $44 |
| Total NC Liab. | $265 | $368 | $338 | $319 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $81 | $90 | $100 |
| Total Liabilities | $398 | $586 | $612 | $545 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$1,889 | -$1,842 | -$1,558 | -$1,264 |
| AOCI | -$6 | -$7 | -$6 | -$4 |
| Other Equity | $1,669 | $1,644 | $1,541 | $1,476 |
| Total Equity | -$226 | -$204 | -$21 | $209 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $42 | $42 | $20 | $20 |
| Total Liab. & Tot. Equity | $215 | $424 | $610 | $774 |
| Net Debt | $40 | $57 | -$66 | -$72 |